Truist Financial analyst David S Macdonald maintained a Hold rating on Pediatrix Medical Group (MD – Research Report) today. The company’s shares closed yesterday at $8.48.
S Macdonald covers the Healthcare sector, focusing on stocks such as Radnet, Cigna, and Option Care Health. According to TipRanks, S Macdonald has an average return of 13.1% and a 64.58% success rate on recommended stocks.
In addition to Truist Financial, Pediatrix Medical Group also received a Hold from Leerink Partners’s Whit Mayo in a report issued on May 7. However, on the same day, Bank of America Securities reiterated a Sell rating on Pediatrix Medical Group (NYSE: MD).
Based on Pediatrix Medical Group’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $496.44 million and a GAAP net loss of $124.29 million. In comparison, last year the company earned a revenue of $513.84 million and had a net profit of $29.66 million
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Pediatrix Medical Group (MD) Company Description:
MEDNAX, Inc. provides physician services including newborn, anesthesia, maternal-fetal, tele radiology, pediatric cardiology and other pediatric subspecialty care. The company’s solution include anesthesiology & pain management, prenatal, neonatal, pediatric, radiology, tele radiology, revenue cycle management and perioperative improvement consulting. MEDNAX was founded by Roger J. Medel in 1979 and is headquartered in Sunrise, FL.
